The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan

OBJECTIVE: The purpose of this double-blind, randomised, placebo-controlled, adaptive design trial with frequent interim analyses is to determine if Australian Indigenous children, who receive an additional (third) dose of human rotavirus vaccine (Rotarix, GlaxoSmithKline) for children aged 6 to <...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Mark A, Graves, Todd, Middleton, Bianca, Totterdell, James, Snelling, Thomas L, Marsh, Julie A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447587/
https://www.ncbi.nlm.nih.gov/pubmed/32843086
http://dx.doi.org/10.1186/s13063-020-04602-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447587/
https://www.ncbi.nlm.nih.gov/pubmed/32843086
http://dx.doi.org/10.1186/s13063-020-04602-w

Ejemplares similares